Literature DB >> 11856802

Genes, microbes, and T cells--new therapeutic targets in Crohn's disease.

Charles O Elson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11856802     DOI： 10.1056/NEJM200202213460812

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn's disease.

Authors:  Eran Israeli; Yaron Ilan
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

2.  CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.

Authors:  B Vander Cruyssen; H Peeters; I E A Hoffman; D Laukens; P Coucke; D Marichal; C Cuvelier; E Remaut; E M Veys; H Mielants; M De Vos; F De Keyser
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 3.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 4.  Immunopathogenesis of inflammatory bowel disease.

Authors:  David Q Shih; Stephan R Targan
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

5.  Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.

Authors:  Carol A Albright; R Balfour Sartor; Susan L Tonkonogy
Journal:  Immunol Lett       Date:  2009-03-03       Impact factor: 3.685

6.  CARD15/NOD2 in a Tunisian population with Crohn's disease.

Authors:  Lilia Zouiten-Mekki; Habib Zaouali; Jalel Boubaker; Sami Karoui; Monia Fekih; Samira Matri; Sami Hamzaoui; Azza Filali; Habiba Chaabouni; Jean Pierre Hugot
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

7.  Plasma long noncoding RNA expression profile identified by microarray in patients with Crohn's disease.

Authors:  Dong Chen; Jiang Liu; Hui-Ying Zhao; Yi-Peng Chen; Zun Xiang; Xi Jin
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

8.  Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2.

Authors:  Yin Shi; En-Hua Zhou; Huan-Gan Wu; Ci-Li Zhou; Qian-Yao Wang; Li Qi
Journal:  Chin J Integr Med       Date:  2011-02-27       Impact factor: 1.978

9.  Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.

Authors:  D Franchimont; S Vermeire; H El Housni; M Pierik; K Van Steen; T Gustot; E Quertinmont; M Abramowicz; A Van Gossum; J Devière; P Rutgeerts
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Nitric oxide inhibitable isoforms of adenylate cyclase mediate epithelial secretory dysfunction following exposure to ionising radiation.

Authors:  S L Freeman; W K MacNaughton
Journal:  Gut       Date:  2004-02       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.